Meet the leaders of MBB, the consulting giants advising the world's most powerful CEOs
They're the leaders of what are widely considered the most prestigious strategy consulting firms: McKinsey & Company, Bain & Company, and Boston Consulting Group, which are collectively referred to as the Big 3, or MBB.
MBB firms are often tough places to land a job, and their consultants are some of the most sought-after in the industry.
They're the people tech giants like Microsoft, Amazon, and Apple — as well as government agencies — turn to for advice on things like mergers and acquisitions, business strategy, and AI adoption. MBB consultants have also gone on to lead some of the world's biggest companies.
So, who's leading the nearly hundred thousand employees across these influential firms?
Here's a look at the leaders at McKinsey, Bain, and BCG.
McKinsey — Bob Sternfels
Bob Sternfels is the global managing partner and chair of the board of directors at McKinsey, which is headquartered in New York City and has offices around the world. The firm employs about 40,000 people.
Senior partners first elected Sternfels in 2021 and re-elected him to a second three-year term in 2024.
Sternfels grew up in California's Central Valley and has worked at McKinsey since 1994, when he joined the San Francisco office. Prior to becoming global managing partner, he led McKinsey's client capabilities around the world. Before that, he ran the operations practice for the Americas and the private equity and principal investors practice globally.
He studied economics and history at Stanford University, where he also played Division I varsity water polo. Sternfels has said on several occasions that his sports background has influenced his leadership style. He got his master's in politics, philosophy, and economics at the University of Oxford, where he was a Rhodes Scholar.
Sternfels recently told Business Insider that humor and vulnerability are some of his key leadership tools. He also said he likes to take small groups on walks when visiting McKinsey offices because it can help folks open up.
"A little levity — a joke at your own expense, a lighthearted moment — can go a long way toward building trust, breaking down barriers, and democratizing the team room," he said.
When he was elected global managing partner, the firm said Sternfels was often described as organized, proactive, and a systems thinker.
Under his leadership, McKinsey has navigated the AI revolution, launching QuantumBlack, the firm's AI consulting arm.
During his tenure, McKinsey has also faced scrutiny for earlier advising Purdue Pharma on how to boost sales of OxyContin. Sternfels testified before Congress in 2022, and the firm has paid about $1.6 billion in recent years to settle legal claims.
McKinsey has also recently reduced its staff by 10%, BI reported in May. The firm said at the time that the reorganization was in part due to AI driving new levels of efficiency and that it planned to hire thousands of new consultants in 2025.
Bain & Company — Christophe De Vusser
Christophe De Vusser is the worldwide managing partner, CEO, and chairman of Bain & Company, which is based in Boston and has about 19,000 employees globally. The company was founded in 1973.
Before taking on the role in July 2024 and moving to New York, De Vusser was a partner based in Brussels, where he led Bain's private equity practice for Europe, the Middle East, and Africa. De Vusser is the first European to hold the role of worldwide managing partner and CEO, the company said in a 2024 press release.
De Vusser, who first joined Bain in 2000, began his career at the consumer products giant Procter & Gamble, maker of Tide detergent and Crest toothpaste. De Vusser has master's degrees in civil engineering and multilingual business communication from the University of Ghent, according to Bain.
De Vusser's rise to the top role comes as the firm's business is evolving because of tech advances. In December, Bain said tech and "AI-enabled revenue" accounted for 30% of the company's business in 2024. Bain expects that revenue to climb to 50% in the coming years.
In a Bain podcast, De Vusser said the firm's clients are grappling with massive amounts of change, including around artificial intelligence. It's a technology, he said, that's still in its early days.
"It will continue to mature at immense speeds, we believe, in the coming decades," he said on the podcast.
De Vusser has also written about AI. In a recent LinkedIn post, he pointed to Bain research that found fewer than 20% of companies had "meaningfully scaled" generative AI. The reason, he said, is that many organizations tend to view AI "primarily as a technology initiative rather than using it as a catalyst to fundamentally reimagine their business."
For organizations to get it right, De Vusser wrote, they need to simplify key processes, use technology so that it fits with strategic goals, and enable workers to use AI.
Boston Consulting Group — Christoph Schweizer
BCG CEO Christoph Schweizer described his leadership style in a video produced by the company: "Values-led, empathetic, transparent, curious," he says.
The firm elected Schweizer for a second term this year. BCG says its reelection process is "unique." All 1,500 managing directors and partners have an equal vote when choosing a CEO.
Schweizer, who first became CEO in 2021, joined BCG in 1997, according to his biography on the firm's website. He holds an MBA from the University of Texas at Austin's McCombs School of Business and a Bachelor's degree from the WHU Otto Beisheim School of Management in Germany.
During his tenure, BCG has grown in several areas, including the firm's investments in AI — which accounted for bout 20% of the firm's total revenue in 2024 and are expected to grow this year, according to a press release from BCG.
Schweizer has also navigated some controversies during his tenure, including two recent projects related to the Gaza conflict. BCG backed out of a multimillion-dollar American-Israeli project to deliver aid in Gaza that was marked by violence. And two senior BCG leaders were demoted for their role in another project that modeled the potential cost of relocating Palestinians from the territory.
One of the firm's biggest challenges moving forward, Schweizer says in the company interview, will be helping clients embed AI.
"To seize the opportunity, our clients need to fundamentally redefine operating models, value chains, decision-making, and end-to-end processes, while protecting themselves from associated risks, such as info security," he said.
Another major focus for BCG is sustainability, he said.
"Companies and governments will have to get serious about decarbonization extremely fast: setting the right targets, reduction mechanisms, metrics, and enforcement," Schweizer said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
UnitedHealth confirms federal investigation into its Medicare practices
UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency. The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations. 'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees. UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services. The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers. Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company. UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
an hour ago
- Business Wire
Offerpad Solutions Inc. Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement
TEMPE, Ariz.--(BUSINESS WIRE)--Offerpad Solutions Inc. ("Offerpad") (NYSE: OPAD), a leading tech-enabled platform for residential real estate, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 2,857,143 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $2.10 per share ('the Registered Offering'). The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million. Share In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,428,571 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.30 per share, will be exercisable commencing six months from the date of issuance, and will expire four years following the initial exercise date. The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million, before deducting placement agent fees and other estimated offering expenses. The Company expects to use the net proceeds from the Offerings for general working capital. A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offerings. The Registered Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-270994) previously filed with the U.S. Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of the proposed Offering will be filed with the SEC and will be available on the SEC's website located at Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@ The private placement of the Common Warrants and the shares underlying the Common Warrants offered to the institutional investor will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). Accordingly, the securities issued in the concurrent private placements may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Offerpad Offerpad, dedicated to simplifying the process of buying and selling homes, is a publicly traded company committed to providing comprehensive solutions that remove the friction from real estate. Our advanced real estate platform offers a range of services, from consumer cash offers to B2B renovation solutions and industry partnership programs, all tailored to meet the unique needs of our clients. Since 2015, we've leveraged local expertise in residential real estate alongside proprietary technology to guide homeowners at every step. #OPAD_IR Forward-Looking Statements This release contains 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as 'believes,' 'expects,' 'anticipates,' 'intends,' 'will,' 'may,' 'should,' or similar expressions. These forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering and uncertainties related to the size, timing, completion, and use of proceeds from the proposed offering. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the Company's business in general, please refer to the Company's prospectus supplement to be filed with the SEC, and the documents incorporated by reference therein, including the Company's Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company has no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise.


CNN
an hour ago
- CNN
UnitedHealth confirms federal investigation into its Medicare practices
Health care policy Medicare Federal agenciesFacebookTweetLink Follow UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency. The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations. 'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees. UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services. The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers. Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company. UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday.